van Rossum J, Wintzen A R, Endtz L J, Schoen J H, de Jonge H
Ann Neurol. 1977 Sep;2(3):238-42. doi: 10.1002/ana.410020310.
In a double-blind controlled clinical trial on 51 patients with subarachnoid hemorrhage, tranexamic acid, 4 gm per day for ten consecutive days, did not favorably affect the outcome. Neither mortality nor rebleeding rates were improved after a follow-up of three months.
在一项针对51例蛛网膜下腔出血患者的双盲对照临床试验中,连续10天每天使用4克氨甲环酸,对预后没有产生有利影响。在三个月的随访期后,死亡率和再出血率均未得到改善。